Finance

Lists
Q3 2026 earnings • released • EPS beat +43.20% • Revenue beat +2.23%
See results
XPER:NYSE
Xperi Inc
$5.36
-0.56%
(-0.030) 1D
$5.76
+7.46% (+0.40)
After hours
Closed: Nov 4, 4:00:02 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XPER...
Open
$5.49
High
$5.63
Low
$5.33
Mkt. cap
261.42M
Avg. vol.
404.11K
Volume
800.36K
52-wk high
$8.75
52-wk low
$4.91
EPS
-$0.70
Beta
0.90
Shares outstanding
48.77M
No. of employees
1K
Open
$5.49
High
$5.63
Low
$5.33
Mkt. cap
261.42M
Avg. vol.
404.11K
Volume
800.36K
52-wk high
$8.75
52-wk low
$4.91
EPS
-$0.70
Beta
0.90
Shares outstanding
48.77M
No. of employees
1K
News stories
From web sources and news partners
About Xperi Inc
CEO-
Employees1.38K
Founded2019
HeadquartersSan Jose, California, United States
SectorSoftware
Industry-
Websitexperi.com
Analyst ratings
Based on 4 analysts giving stock ratings to XPER in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for XPER in the last 3 months.
Highest
Current $5.36
$13.00 (+142.54%)
Average
$11.25 (+109.89%)
Lowest
$10.00 (+86.57%)
Analyst
Recommendation
Action
Price target
Projected
Date
Hamed Khorsand
BWS Financial
Buy
Maintained
$12.00
+123.9%
08/07/2026
Matthew Galinko
Maxim Group
Buy
Maintained
$13.00
+142.5%
08/07/2026
Steve Frankel
Rosenblatt Securities
Buy
Maintained
$10.00
+86.6%
08/06/2026
Jason Kreyer
Craig-Hallum
Buy
Maintained
$10.00
+86.6%
08/06/2026
Unknown Analyst
Rosenblatt Securities
Buy
Maintained
$10.00
+86.6%
05/06/2026
Last report
Just released
Today, 12:00 AM
Fiscal period
Q3 2026
$0.24 / $0.17
+43.20%beat
Revenue / Est. (USD)
113.95M / 111.47M
+2.23%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
111.63M
116.51M
114.21M
114.49M
Cost of goods sold
29.08M
32.12M
30.88M
36.07M
Cost of revenue
29.08M
32.12M
30.88M
36.07M
Research and development expenses
29.92M
27.85M
27.08M
21.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42.54M
45.86M
41.79M
41.46M
Operating expense
83.92M
85.30M
81.18M
75.31M
Total operating expenses
112.99M
117.42M
112.06M
111.38M
Operating income
-1.36M
-908.00K
2.15M
3.11M
Other non operating income
-
-
-
-
EBT including unusual items
-1.30M
-14.29M
2.29M
3.33M
EBT excluding unusual items
-1.30M
-405.00K
2.29M
3.52M
Income tax expense
4.80M
2.79M
10.12M
4.83M
Effective tax rate
-369.05%
-19.53%
441.45%
145.10%
Other operating expenses
-
-
-
-
Net income
-6.11M
-17.08M
-7.83M
-1.50M
Net profit margin
-5.47%
-14.66%
-6.85%
-1.31%
Earnings per share
0.28
0.24
0.23
0.28
Interest and investment income
821.00K
1.23M
819.00K
1.10M
Interest expense
-761.00K
-727.00K
-678.00K
-684.00K
Net interest expenses
60.00K
503.00K
141.00K
413.00K
Depreciation and amortization charges
3.47M
3.60M
4.26M
3.95M
EBITDA
13.34M
3.44M
11.62M
12.59M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps